These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 38635863)
1. A 700 nm LED Light Activated Ru(II) Complex Destroys Tumor Cytoskeleton via Photosensitization and Photocatalysis. Dao A; Chen S; Pan L; Ren Q; Wang X; Wu H; Gong Q; Chen Z; Ji S; Ru J; Zhu H; Liang C; Zhang P; Xia H; Huang H Adv Healthc Mater; 2024 Sep; 13(23):e2400956. PubMed ID: 38635863 [TBL] [Abstract][Full Text] [Related]
2. Dinuclear Tridentate Ru(II) Complex with Strong Near-Infrared Light-Triggered Anticancer Activity. Wei L; Kushwaha R; Sadhukhan T; Wu H; Dao A; Zhang Z; Zhu H; Gong Q; Ru J; Liang C; Zhang P; Banerjee S; Huang H J Med Chem; 2024 Jul; 67(13):11125-11137. PubMed ID: 38905437 [TBL] [Abstract][Full Text] [Related]
3. Donor-Acceptor-Donor Strategy Rouses the Photodynamic Therapy Anticancer Activity of a Bis-terpyridyl Ru(II) Complex. Wang Z; Wei L; Lin J; Huang C; Chen H; Fan D; Hu W; Liu J; Huang H; Wang Z; Wang X J Med Chem; 2024 Aug; 67(15):13435-13445. PubMed ID: 39078925 [TBL] [Abstract][Full Text] [Related]
5. Photophysical Properties and Photobiological Activities of Ruthenium(II) Complexes Bearing π-Expansive Cyclometalating Ligands with Thienyl Groups. McCain J; Colón KL; Barrett PC; Monro SMA; Sainuddin T; Roque Iii J; Pinto M; Yin H; Cameron CG; McFarland SA Inorg Chem; 2019 Aug; 58(16):10778-10790. PubMed ID: 31386351 [TBL] [Abstract][Full Text] [Related]
6. π-Expansive Heteroleptic Ruthenium(II) Complexes as Reverse Saturable Absorbers and Photosensitizers for Photodynamic Therapy. Wang L; Yin H; Jabed MA; Hetu M; Wang C; Monro S; Zhu X; Kilina S; McFarland SA; Sun W Inorg Chem; 2017 Mar; 56(6):3245-3259. PubMed ID: 28263079 [TBL] [Abstract][Full Text] [Related]
7. The Development of Ru(II)-Based Photoactivated Chemotherapy Agents. Chen Y; Bai L; Zhang P; Zhao H; Zhou Q Molecules; 2021 Sep; 26(18):. PubMed ID: 34577150 [TBL] [Abstract][Full Text] [Related]
8. A Ru-anthraquinone dyad with triple functions of PACT, photoredox catalysis and PDT upon red light irradiation. Zhang C; Guo X; Da X; Wang Z; Wang X; Zhou Q Dalton Trans; 2021 Aug; 50(31):10845-10852. PubMed ID: 34296720 [TBL] [Abstract][Full Text] [Related]
9. A nuclear permeable Ru(ii)-based photoactivated chemotherapeutic agent towards a series of cancer cells: in vitro and in vivo studies. Tian N; Feng Y; Sun W; Lu J; Lu S; Yao Y; Li C; Wang X; Zhou Q Dalton Trans; 2019 May; 48(19):6492-6500. PubMed ID: 30994660 [TBL] [Abstract][Full Text] [Related]
11. Insights into the anticancer photodynamic activity of Ir(III) and Ru(II) polypyridyl complexes bearing β-carboline ligands. Sanz-Villafruela J; Bermejo-Casadesus C; Zafon E; Martínez-Alonso M; Durá G; Heras A; Soriano-Díaz I; Giussani A; Ortí E; Tebar F; Espino G; Massaguer A Eur J Med Chem; 2024 Oct; 276():116618. PubMed ID: 38972079 [TBL] [Abstract][Full Text] [Related]
12. Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives. Lee SY; Kim CY; Nam TG Drug Des Devel Ther; 2020; 14():5375-5392. PubMed ID: 33299303 [TBL] [Abstract][Full Text] [Related]
13. Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity. Li S; Zhao J; Wang X; Xu G; Gou S; Zhao Q Inorg Chem; 2020 Aug; 59(15):11193-11204. PubMed ID: 32702972 [TBL] [Abstract][Full Text] [Related]
14. Visible-Light-Responsive Novel Ru(II)-Metallo-Antibiotics with Potential Antibiofilm and Antibacterial Activity. Mandal AA; Upadhyay A; Mandal A; Nayak M; K MS; Mukherjee S; Banerjee S ACS Appl Mater Interfaces; 2024 Jun; 16(22):28118-28133. PubMed ID: 38783713 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of action of Ru(ii) polypyridyl complexes in living cells upon light irradiation. Jakubaszek M; Goud B; Ferrari S; Gasser G Chem Commun (Camb); 2018 Nov; 54(93):13040-13059. PubMed ID: 30398487 [TBL] [Abstract][Full Text] [Related]
16. Fusion of photodynamic therapy and photoactivated chemotherapy: a novel Ru(II) arene complex with dual activities of photobinding and photocleavage toward DNA. Chen Y; Lei W; Jiang G; Hou Y; Li C; Zhang B; Zhou Q; Wang X Dalton Trans; 2014 Nov; 43(41):15375-84. PubMed ID: 25188424 [TBL] [Abstract][Full Text] [Related]
17. A Dinuclear Ruthenium(II) Complex Excited by Near-Infrared Light through Two-Photon Absorption Induces Phototoxicity Deep within Hypoxic Regions of Melanoma Cancer Spheroids. Raza A; Archer SA; Fairbanks SD; Smitten KL; Botchway SW; Thomas JA; MacNeil S; Haycock JW J Am Chem Soc; 2020 Mar; 142(10):4639-4647. PubMed ID: 32065521 [TBL] [Abstract][Full Text] [Related]
18. A mitochondria-targeting dinuclear Ir-Ru complex as a synergistic photoactivated chemotherapy and photodynamic therapy agent against cisplatin-resistant tumour cells. Zhang C; Guan R; Liao X; Ouyang C; Rees TW; Liu J; Chen Y; Ji L; Chao H Chem Commun (Camb); 2019 Oct; 55(83):12547-12550. PubMed ID: 31576841 [TBL] [Abstract][Full Text] [Related]
19. Kinetically labile ruthenium(II) complexes of terpyridines and saccharin: effect of substituents on photoactivity, solvation kinetics, and photocytotoxicity. Kumar P; Singh P; Saren S; Pakira S; Sivakumar S; Patra AK Dalton Trans; 2021 Jun; 50(23):8196-8217. PubMed ID: 34031678 [TBL] [Abstract][Full Text] [Related]